Garadacimab for hereditary angioedema prophylaxis: Efficacy and safety from a Phase 2 open-label extension trialT. J. Craig,A. Reshef,W. R. Lumry,I. Martinez Saguer,J. S. Jacobs, W. H. Yang,E. Aygoren-Pursun,P. K. Keith,P. Busse,M. Magerl,H. Feuersenger, M. A. Bica, F. Glassman,I. Pragst,D. S. LevyALLERGOLOGIE(2023)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要